Interventions before and after birth can reduce the rising maternal mortality ratio.
Recommendations for maternity care professionals based on MiPATH.
A meta-analysis of over 1 million pregnant women in China reveals a 30% anemia prevalence, with significant variations across regions, urban and rural areas, and trimesters.
Despite a $350 billion market potential for menopause treatment, a disconnect persists between women and health care providers, highlighting the need for personalized, trust-building strategies.
Halley Crissman, MD, MPH, shares her insight on the ways in which hospital systems reinforce cisnormativity and focal points to address for a more welcoming environment.
When considering the “health” of a medical practice, much of the focus is on financial indicators: missing collections at the time of service, recurring denials, poor claims management and aging patient balances. However, another area needs attention but is often overlooked: patient satisfaction.
The protocol presented here provides an algorithm for the initial evaluation of anemia in pregnancy, with treatment algorithms for the most common causes in pregnancy.
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
Correct terms and education can help normalize the conversation for patients.
Women experiencing menopause later in life may face an increased risk of asthma, according to recent research highlighting the impact of hormone levels on respiratory health.
Sweeping policy-level implementation efforts have mandated SDM in other areas of medicine; similar mandates could impact ob/gyn.
Standard chemotherapy has historically been the mainstay of treatment for patients with diagnoses of early-stage TNBC, but there remains an unmet need to identify novel therapies that improve outcomes and, equally important, to discern which patients may benefit from a given treatment.
Explore the potential benefits and considerations of utilizing intraurethral lidocaine jelly during urodynamic studies for bladder testing, as we delve into research findings on patient discomfort, voiding metrics, and diagnostic precision.
Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler share practice pearls for HPV and cervical cancer screening and express their hope for emerging testing options.
Among 43 cycles that achieved pregnancy, investigators observed decreases of annualized relapse rates from 0.26 to 0.09.
On May 19, 2021, Governor Greg Abbott signed Texas Senate Bill 8 (also known as the Fetal Heartbeat Bill) into law with the statement that this will save lives in the state of Texas. This law is recognized as the most restrictive anti-abortion regulation in the United States today.
Mubashir S. Billah, MD, discusses a study presented at the 2024 AUA Annual Meeting, which evaluates the efficacy of AI-generated summaries against traditional human-written summaries in the field of incontinence research.
In this episode, clinicians discuss challenges associated with these topics and offer some insights on them.
In this video interview, Senior Editor Angie DeRosa talks with Linda Fan, MD, about the rise of telehealth as the pandemic enters the second stage.
Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the role of surgery and GnRh agonists for the treatment of endometriosis.
In today’s world, it is easy to find information on the internet, whether it be through search engines or social media. Much of that information, however, is not reliable.
In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.
The combination of lenvatinib plus pembrolizumab induced durable responses with a manageable safety profile in adults with previously treated, advanced endometrial cancer, according to a long-term follow-up analysis of a phase 1b/2 study (NCT02501096).
Understanding signs, symptoms helps determine the best treatment regimen